北アメリカ（NAFTA）の医薬品業界のプロファイルは、市場シェア、市場規模（2017 〜 2021 年の値、および 2026 年までの予測）などのトップラインの定性的および定量的概要情報を提供します。プロフィールには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 NAFTA Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Mexico
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in The United States
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Company Profiles
9.1. Apotex, Inc.
9.2. Bayer AG
9.3. Novartis AG
9.4. Johnson & Johnson
9.5. Pfizer Inc.
9.6. Merck & Co., Inc.
9.7. AstraZeneca PLC
10 Appendix
10.1. Methodology
10.2. About MarketLine
List of Tables
Table 1: NAFTA countries pharmaceuticals industry, revenue ($bn), 2017-26
Table 2: NAFTA countries pharmaceuticals industry, revenue ($bn), 2017-21
Table 3: NAFTA countries pharmaceuticals industry forecast, revenue ($bn), 2021-26
Table 4: Canada pharmaceuticals market value: $ billion, 2016-21
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2021
Table 6: Canada pharmaceuticals market share: % share, by value, 2021
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2021-26
Table 8: Canada size of population (million), 2017-21
Table 9: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 10: Canada gdp (current prices, $ billion), 2017-21
Table 11: Canada inflation, 2017-21
Table 12: Canada consumer price index (absolute), 2017-21
Table 13: Canada exchange rate, 2017-21
Table 14: Mexico pharmaceuticals market value: $ billion, 2016-21
Table 15: Mexico pharmaceuticals market geography segmentation: $ billion, 2021
Table 16: Mexico pharmaceuticals market share: % share, by value, 2021
Table 17: Mexico pharmaceuticals market value forecast: $ billion, 2021-26
Table 18: Mexico size of population (million), 2017-21
Table 19: Mexico gdp (constant 2005 prices, $ billion), 2017-21
Table 20: Mexico gdp (current prices, $ billion), 2017-21
Table 21: Mexico inflation, 2017-21
Table 22: Mexico consumer price index (absolute), 2017-21
Table 23: Mexico exchange rate, 2017-21
Table 24: United States pharmaceuticals market value: $ billion, 2016-21
Table 25: United States pharmaceuticals market geography segmentation: $ billion, 2021
Table 26: United States pharmaceuticals market share: % share, by value, 2021
Table 27: United States pharmaceuticals market value forecast: $ billion, 2021-26
Table 28: United States size of population (million), 2017-21
Table 29: United States gdp (constant 2005 prices, $ billion), 2017-21
Table 30: United States gdp (current prices, $ billion), 2017-21
Table 31: United States inflation, 2017-21
Table 32: United States consumer price index (absolute), 2017-21
Table 33: United States exchange rate, 2017-21
Table 34: Apotex, Inc.: key facts
Table 35: Apotex, Inc.: Key Employees
Table 36: Bayer AG: key facts
Table 37: Bayer AG: Annual Financial Ratios
Table 38: Bayer AG: Key Employees
Table 39: Bayer AG: Key Employees Continued
Table 40: Novartis AG: key facts
Table 41: Novartis AG: Annual Financial Ratios
Table 42: Novartis AG: Key Employees
Table 43: Novartis AG: Key Employees Continued
Table 44: Johnson & Johnson: key facts
Table 45: Johnson & Johnson: Annual Financial Ratios
Table 46: Johnson & Johnson: Key Employees
Table 47: Johnson & Johnson: Key Employees Continued
Table 48: Pfizer Inc.: key facts
Table 49: Pfizer Inc.: Annual Financial Ratios
Table 50: Pfizer Inc.: Key Employees
Table 51: Pfizer Inc.: Key Employees Continued
Table 52: Merck & Co., Inc.: key facts
Table 53: Merck & Co., Inc.: Annual Financial Ratios
Table 54: Merck & Co., Inc.: Key Employees
Table 55: Merck & Co., Inc.: Key Employees Continued
Table 56: AstraZeneca PLC: key facts
Table 57: AstraZeneca PLC: Annual Financial Ratios
Table 58: AstraZeneca PLC: Key Employees
Table 59: AstraZeneca PLC: Key Employees Continued
List of Figures
Figure 1: NAFTA countries pharmaceuticals industry, revenue ($bn), 2017-26
Figure 2: NAFTA countries pharmaceuticals industry, revenue ($bn), 2017-21
Figure 3: NAFTA countries pharmaceuticals industry forecast, revenue ($bn), 2021-26
Figure 4: Canada pharmaceuticals market value: $ billion, 2016-21
Figure 5: Canada pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 6: Canada pharmaceuticals market share: % share, by value, 2021
Figure 7: Canada pharmaceuticals market value forecast: $ billion, 2021-26
Figure 8: Forces driving competition in the pharmaceuticals market in Canada, 2021
Figure 9: Drivers of buyer power in the pharmaceuticals market in Canada, 2021
Figure 10: Drivers of supplier power in the pharmaceuticals market in Canada, 2021
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2021
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2021
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2021
Figure 14: Mexico pharmaceuticals market value: $ billion, 2016-21
Figure 15: Mexico pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 16: Mexico pharmaceuticals market share: % share, by value, 2021
Figure 17: Mexico pharmaceuticals market value forecast: $ billion, 2021-26
Figure 18: Forces driving competition in the pharmaceuticals market in Mexico, 2021
Figure 19: Drivers of buyer power in the pharmaceuticals market in Mexico, 2021
Figure 20: Drivers of supplier power in the pharmaceuticals market in Mexico, 2021
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2021
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2021
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2021
Figure 24: United States pharmaceuticals market value: $ billion, 2016-21
Figure 25: United States pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 26: United States pharmaceuticals market share: % share, by value, 2021
Figure 27: United States pharmaceuticals market value forecast: $ billion, 2021-26
Figure 28: Forces driving competition in the pharmaceuticals market in the United States, 2021
Figure 29: Drivers of buyer power in the pharmaceuticals market in the United States, 2021
Figure 30: Drivers of supplier power in the pharmaceuticals market in the United States, 2021
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2021
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2021
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2021
